Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1847-1852

  De Franceschi, Lucia ^a   Bachir, Dora ^b   Galacteros, Frederic ^b   Tchernia, Gil ^c   Cynober, Therese ^c   Alper, Seth ^d   Platt, Orah ^e   Beuzard, Yves ^f   Brugnara, Carlo ^e  

^a UNIVERSITY OF VERONA   (Italy)

^b HENRI MONDOR HOSPITAL   (France)

^c BICÊTRE HOSPITAL   (France)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

Antisickling agents; Carrier proteins; Erythrocytes; Potassium; Sickle cell

Indexed keywords

ANTISICKLING AGENT; CARRIER PROTEIN; CHLORIDE; POTASSIUM; PYROGLUTAMATE MAGNESIUM;

ARTICLE; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFECT; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; ORAL DRUG ADMINISTRATION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0030964677     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119713     Document Type: Article

References (42)

1. Eaton, W.A., and J. Hofrichter. 1987. Hemoglobin S gelation and sickle cell disease. Blood. 70:1245-1266.
2. Noguchi, C.T., G.P. Rodgers, and A.N. Schechter. 1989. Intracellular polymerization. Disease severity and therapeutic predictions. Ann. NY Acad. Sci. 565:75-82.
3. Clark, M.R., C.E. Morrison, and S.B. Shohet. 1978. Monovalent cation transport in irreversibly sickle cells. J. Clin. Invest. 62:329-337.
4. Bertles, J.F., and P.P.A. Milner. 1968. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle cell anemia. J. Clin. Invest. 47:1731-1741.
5. Platt, O.S., S.H. Orkin, G. Dover, G.P. Beardsley, B. Miller, and D.G. Nathan. 1984. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J. Clin. Invest. 74:652-656.
6. Charache, S., M.L. Terrin, R.D. Moore, G.J. Dover, F.B. Barton, S.V. Eckert, R.P. McMahon, and D.R. Bonds. 1995. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332:1317-1322.
7. Bridges, K.R., G.D. Barabino, C. Brugnara, M. Cho, G.W. Christoph, G. Dover, B. Ewenstein, D.E. Golan, C.R.G. Guttmann, J. Hofrichter et al. 1996. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood. 88:4701-4710.
8. Gardos, G. 1958. The function of calcium in the potassium permeability of human erythrocytes. Biochim. Biophys. Acta. 30:653-654.
9. Brugnara, C., H.F. Bunn, and D.C. Tosteson. 1986. Regulation of erythrocyte cation and water content in sickle cell anemia. Science (Wash. DC). 232: 388-390.
10. Joiner, C.H. 1993. Cation transport and volume regulation in sickle red blood cells. Am. J. Physiol. (Cell Physiol. 33) 264:C251-C270.
11. + channels by cytochrome P-450 inhibitors. J. Biol. Chem. 267:11789-11793.
12. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 92:520-526.
13. + transport and reverses erythrocyte dehydration in transgenic SAD mice: a model for therapy of sickle cell disease. J. Clin. Invest. 93:1670-1676.
14. Brugnara, C., B. Gee, C. Armsby, S. Kurth, M. Sakamoto, N. Rifai, S.L. Alper, and O.S. Platt. 1996. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J. Clin. Invest. 97:1227-1234.
15. Brugnara, C., and D.C. Tosteson. 1987. Cell volume, K transport and cell density in human erythrocytes. Am. J. Physiol. (Cell Physiol. 21)252:C269-C276.
16. Brugnara, C., and D.C. Tosteson. 1987. Inhibition of K transport by divalent cations in sickle erythrocytes. Blood. 70:1810-1815.
17. ++ modulation. Blood. 70:1861-1866.
18. Paolisso, G., A. Scheen, D. Cozzolino, G. Di Maro, M. Varricchio, F. D'Onofrio, and P.J. Lefebvre. 1994. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J. Clin. Endocrinol. Metab. 78:1510-1514.
19. Borclla, P., G. Ambrosini, M. Concari, and A. Bargellini. 1993. Is magnesium content in erythrocytes suitable for evaluating cation retention after oral physiological supplementation in marginally magnesium-deficient subjects? Magnes. Res. 6:149-153.
20. De Franceschi, L., Y. Beuzard, H. Jouault, and C. Brugnara. 1996. Modulation of erythrocyte potassium-chloride cotransport, potassium content and density by dietary magnesium intake in transgenic SAD mouse. Blood. 88:2738-2744.
21. Britton, J., I. Pavord, K. Richards, A. Wisniewski, A. Knox, S. Lewis, A. Tattersfield, and S. Weiss. 1994. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in random adult population sample. Lancet. 344: 357-362.
22. Mohandas, N., Y.R. Kim, D.H. Tycko, J. Orlik, J. Wyatt, and W. Groner. 1986. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood. 68: 506-513.
23. Mohandas, N., A. Johnson, J. Wyatt, L. Croisille, J. Reeves, D. Tycko, and W. Groner. 1989. Automated quantitation of cell density distribution and hyperdense cell fraction in RBC disorders. Blood. 74:442-447.
24. Brugnara, C., M.J. Hipp, P.J. Irving, H. Lathrop, P.A. Lee, E.M. Minchello, and J. Winkelman. 1994. Automated reticulocyte counting and measurement of reticulocyte cellular indices: evaluation of the Miles H*3 blood analyzer. Am. J. Clin. Pathol. 102:623-632.
25. Danon, D., and Y. Marikovsky. 1964. Determination of density distribution of red cell population. J. Lab. Clin. Med. 64:668-674.
26. Rodgers, G.P., A.N. Sehechter, and C.T. Noguchi. 1985. Cell heterogeneity in sickle cell disease: quantitation of the erythrocyte density profile. J. Lab. Clin. Med. 106:30-37.
27. Brugnara, C., A. Kopin, H.F. Bunn, and D.C. Tosteson. 1985. Regulation of cation content and cell volume in erythrocytes from patients with homozygous hemoglobin C disease. J. Clin. Invest. 75:1608-1617.
28. Clark, M.R., M. Narla, and S.B. Shohet. 1983. Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood. 61:899-910.
29. Cynober, T., M. Narla, and G. Tchernia. 1996. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J. Lab. Clin. Med. 128:259-269.
30. Godfrey, K. 1985. Comparing the means of several groups. N Engl. J. Med. 313:1450-1456.
31. Ortiz, O.E, V.L. Lew, and R.M. Bookchin. 1990. Deoxygenation permeabilizes sickle cell anaemia red cells to magnesium and reverses its gradient in the dense cells. J. Physiol. (Lond.). 427:211-226.
32. Olukoga, A.O., H.O. Adewoye, R.T. Erasmus, and M.A. Adedoyin. 1990. Erythrocyte and plasma magnesium in sickle-cell anaemia. East Afr. Med. J. 67:348-354.
33. 2+ transport system in human red blood cells. Biochim. Biophys. Acta. 856:76-84.
34. Bernstein, R.E. 1959. Alterations in metabolic energetics and cation transport during aging of red cells. J. Clin. Invest. 38:1572-1586.
35. Ginsburg, S., J.G. Smith, P.M. Ginsburg, J.Z. Reardon, and J.K. Aikawa. 1962. Magnesium metabolism of human and rabbit erythrocytes. Blood. 20:722-729.
36. Feray, J.C., Y. Beuzard, and R.P. Garay. 1988. Na/Mg exchange in sickle cells. VI International Magnesium Symposium. 22a. (Abstr.).
37. Franco, R.S., M. Palascak, H. Thompson, and C.H. Joiner. 1995. K/Cl cotransport activity in light versus dense transferrin receptor-positive reticulocytes. J. Clin. Invest. 95:2573-2580.
38. Flatman, P.W., and V.L. Lew. 1981. The magnesium-dependence of sodium-pump-mediated sodium-potassium and sodium-sodium exchange in intact human red cells. J. Physiol. (Lond.). 315:421-446.
39. Franco, R.S., M. Palascak, H. Thompson, D.K. Rucknagel, and C.H. Joiner. 1996. Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: role of KCl cotransport and extracellular Ca. Blood. 88:4359-4365.
40. Anstall, H.B., R.G. Huntsman, H. Lehmann, G.H. Hayward, and D. Weitzman. 1959. The effect of magnesium on blood coagulation in human subjects. Lancet. 1:814-815.
41. Lehmann, H. 1963. Treatment of sickle cell anemia. Br. Med. J. 1:1158-1159.
42. Basu, A.K., and A.W. Woodruff. 1966. Effect of acetazolamide and magnesium therapy on erythrocyte survival in sickle-cell anemia and sickle-cell-haemoglobin-C disease. Trans. R. Soc. Trop. Med. Hyg. 60:64-69.